OmniAb, Inc. operates as a drug discovery company. The firm focuses on developing human monoclonal and bispecific therapeutic antibodies. Its platform includes the biological intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse. The company was founded on December 14, 2015 and is headquartered in Emeryville, CA.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
89
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. OmniAb Inc market cap is $679.71M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. OmniAb Inc 52 week high is $5.45 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. OmniAb Inc 52 week low is $1.35 as of November 21, 2026.
OmniAb Inc stock price today is $4.66.
OmniAb Inc stock price yesterday was $5.03.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. OmniAb Inc's P/E ratio is -13.78.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. OmniAb Inc P/B ratio is 2.7279.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. OmniAb Inc 50-day moving average is $4.82.